Carlo Colosimo is an expert in Neurology at Azienda Ospedaliera S.Maria (Italy). As of October 2026, ScienceLeadR ranks Carlo Colosimo in the top 1% of experts worldwide for Basal Ganglia Diseases. Carlo Colosimo has authored 317 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 999 (community average: 125). How the SLR is computed.

LeadR Profile

Carlo Colosimo Azienda Ospedaliera S.Maria Italy
999 ScienceLeadR Reputation 999
Network Map

Neurology

Subspecialties: Biochemistry - Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2026

Source: PubMed

Azienda Ospedaliera S.Maria

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 317

Citations

Citations: 18 926 1st author: 40 Last author: 79 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Genetic and environmental risk factors of Parkinsonism.
PMID 41940964 — parkinsonian disorders, risk factors, synaptic transmission
J Neural Transm (Vienna)20260
OUTCOMES PREDICTORS IN PATIENTS WITH BASILAR ARTERY OCCLUSION AND MILD DEFICITS, TREATED WITH MECHANICAL THROMBECTOMY: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY.
PMID 41698454 — arteries, signs and symptoms, cerebrovascular disorders, thrombectomy, basilar artery
J Stroke Cerebrovasc Dis20260
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
PMID 41039230 — headache, registries, comorbidity, life style, sleep, phenotype, migraine disorders, public health, signs and symptoms
J Headache Pain20252
The "gunslinger" sign in neurological disorders.
PMID 40945465 — nervous system diseases, neurology
J Neurol Sci20250
Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy.
PMID 40884249 — supranuclear palsy, progressive, atrophy, brain, movement disorders, paralysis
Mov Disord20250

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 3
Phase 2 2
Phase 1 1

By status:

Completed 2
Recruiting 2
Active not recruiting 1
Terminated 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
2024-517529-26-00 — safety, polyneuropathies
Phase 3Recruiting2025
Open Label Extension of TUDCA ALS Study
NCT05753852 — sclerosis, bile, safety, neurons, motor neurons, deoxycholic acid, capsules, amyotrophic lateral sclerosis, motor neuron disease, meals
Phase 3Recruiting2021

LeadR Networks

Main global connection map